Influence of the viral regulatory region on tumor induction by simian virus 40 in hamsters

Journal of Virology

Volumn 82, Issue 2, 2008, Pages 871-879

  Sroller, Vojtech ^a   Vilchez, Regis A ^a,b   Stewart, A Renee ^a   Wong, Connie ^a   Butel, Janet S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIBODY; VIRUS LARGE T ANTIGEN; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CARCINOGENICITY; CELL LINE; CONTROLLED STUDY; ENHANCER REGION; FEMALE; GENETIC CODE; HAMSTER; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN STRUCTURE; SIMIAN VIRUS 40; STATISTICAL SIGNIFICANCE; VIRUS INFECTION; VIRUS LOAD; VIRUS STRAIN;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CRICETINAE; ENHANCER ELEMENTS (GENETICS); FIBROBLASTS; GENE REARRANGEMENT; INCIDENCE; MICE; NEOPLASMS; RECOMBINATION, GENETIC; SIMIAN VIRUS 40;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS; SIMIAN VIRUS 40;

EID: 37848998737     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01626-07     Document Type: Article

References (57)

1. Ahuja, D., M. T. Sáenz-Robles, and J. M. Pipas. 2005. SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24:7729-7745.
2. Amalfitano, A., L. G. Martin, and M. M. Fluck. 1992. Different roles for two enhancer domains in the organ- and age-specific pattern of polyomavirus replication in the mouse. Mol. Cell. Biol. 12:3628-3635.
3. +-T-lymphocyte responses. J. Virol. 78:2247-2254.
4. Burd, E. M. 2003. Human papillomavirus and cervical cancer. Clin. Microbiol. Rev. 16:1-17.
5. Butel, J. S. 2000. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 21:405-426.
6. Butel, J. S. SV40, human infections, and cancer: emerging concepts and causality considerations. In K. Khalili and K. T. Jeang (ed.), Viral oncology: basic science and clinical applications, in press. Blackwell Publishing Ltd., Oxford, United Kingdom.
7. Butel, J. S., A. S. Arrington, C. Wong, J. A. Lednicky, and M. J. Finegold. 1999. Molecular evidence of simian virus 40 infections in children. J. Infect. Dis. 180:884-887.
8. Butel, J. S., S. Jafar, C. Wong, A. S. Arrington, A. R. Opekun, M. J. Finegold, and E. Adam. 1999. Evidence of SV40 infections in hospitalized children. Hum. Pathol. 30:1496-1502.
9. Butel, J. S., and J. A. Lednicky. 1999. Cell and molecular biology of simian virus 40: implications for human infections and disease. J. Natl. Cancer Inst. 91:119-134.
10. Butel, J. S., S. S. Tevethia, and J. L. Melnick. 1972. Oncogenicity and cell transformation by papovavirus SV40: the role of the viral genome. Adv. Cancer Res. 15:1-55.
11. Cicala, C., F. Pompetti, and M. Carbone. 1993. SV40 induces mesotheliomas in hamsters. Am. J. Pathol. 142:1524-1533.
12. Cole, C. N., L. V. Crawford, and P. Berg. 1979. Simian virus 40 mutants with deletions at the 3′ end of the early region are defective in adenovirus helper function. J. Virol. 30:683-691.
13. Cubitt, C. L. 2006. Molecular genetics of the BK virus, p. 85-95. In N. Ahsan (ed.), Polyomaviruses and human diseases. Springer Science, Georgetown, TX.
14. Cutrone, R., J. Lednicky, G. Dunn, P. Rizzo, M. Bocchetta, K. Chumakov, P. Minor, and M. Carbone. 2005. Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. Cancer Res. 65:10273- 10279.
15. Dang, X., M. K. Axthelm, N. L. Letvin, and I. J. Koralnik. 2005. Rearrangement of simian virus 40 regulatory region is not required for induction of progressive multifocal leukoencephalopathy in immunosuppressed rhesus monkeys. J. Virol. 79:1361-1366.
16. Diamandopoulos, G. T. 1973. Induction of lymphocytic leukemia, lymphosarcoma, reticulum cell sarcoma, and osteogenic sarcoma in the Syrian golden hamster by oncogenic DNA simian virus 40. J. Natl. Cancer Inst. 50:1347-1365.
17. Dubensky, T. W., and L. P. Villarreal. 1984. The primary site of replication alters the eventual site of persistent infection by polyomavirus in mice. J. Virol. 50:541-546.
18. Forsman, Z. H., J. A. Lednicky, G. E. Fox, R. C. Willson, Z. S. White, S. J. Halvorson, C. Wong, A. M. Lewis, Jr., and J. S. Butel. 2004. Phylogenetic analysis of polyomavirus simian virus 40 from monkeys and humans reveals genetic variation. J. Virol. 78:9306-9316.
19. Freund, R., C. J. Dawe, and T. L. Benjamin. 1988. Duplication of noncoding sequences in polyomavirus specifically augments the development of thymic tumors in mice. J. Virol. 62:3896-3899.
20. 40. Proc. Soc. Exp. Biol. Med. 109:649-660.
21. Institute of Laboratory Animal Resources Committee on Care and Use of Laboratory Animals. 1978. Guide for the care and use of laboratory animals. Department of Health and Human Services publication no. (NIH) 78-23, Bethesda, MD.
22. Jasani, B., A. Cristaudo, S. A. Emri, A. F. Gazdar, A. Gibbs, B. Krynska, C. Miller, L. Mutti, C. Radu, M. Tognon, and A. Procopio. 2001. Association of SV40 with human tumours. Semin. Cancer Biol. 11:49-61.
23. Krieg, P., and G. Scherer. 1984. Cloning of SV40 genomes from human brain tumors. Virology 138:336-340.
24. Lednicky, J. A., A. S. Arrington, A. R. Stewart, X. M. Dai, C. Wong, S. Jafar, M. Murphey-Corb, and J. S. Butel. 1998. Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease. J. Virol. 72:3980-3990.
25. Lednicky, J. A., and J. S. Butel. 1997. Tissue culture adaptation of natural isolates of simian virus 40: changes occur in viral regulatory region but not in carboxy-terminal domain of large T-antigen. J. Gen. Virol. 78:1697-1705.
26. Lednicky, J. A., and J. S. Butel. 1998. Consideration of PCR methods for the detection of SV40 in tissue and DNA specimens. Dev. Biol. Stand. 94:155-164.
27. Lednicky, J. A., and J. S. Butel. 2001. Simian virus 40 regulatory region structural diversity and the association of viral archetypal regulatory regions with human brain tumors. Semin. Cancer Biol. 11:39-47.
28. Lednicky, J. A., R. L. Garcea, D. J. Bergsagel, and J. S. Butel. 1995. Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology 212:710-717.
29. Lednicky, J. A., A. R. Stewart, J. J. Jenkins III, M. J. Finegold, and J. S. Butel. 1997. SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes. Int. J. Cancer 72:791-800.
30. Lednicky, J. A., C. Wong, and J. S. Butel. 1995. Artificial modification of the viral regulatory region improves tissue culture growth of SV40 strain 776. Virus Res. 35:143-153.
31. Li, R. M., M. H. Branton, S. Tanawattanacharoen, R. A. Falk, J. C. Jennette, and J. B. Kopp. 2002. Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J. Am. Soc. Nephrol. 13:2320-2330.
32. Li, R. M., R. B. Mannon, D. Kleiner, M. Tsokos, M. Bynum, A. D. Kirk, and J. B. Kopp. 2002. BK virus and SV40 co-infection in polyomavirus nephropathy. Transplantation 74:1497-1504.
33. McNees, A. L., and J. S. Butel. Simian virus 40 (Polyomaviridae). In B. Mahy and M. Van Regenmortel (ed.), Encyclopedia of virology, in press. Elsevier, New York, NY.
34. McNees, A. L., Z. S. White, P. Zanwar, R. A. Vilchez, and J. S. Butel. 2005. Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR. J. Clin. Virol. 34:52-62.
35. Melnick, J. L., and S. Stinebaugh. 1962. Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine. Proc. Soc. Exp. Biol. Med. 109:965-968.
36. Moens, U., and M. Van Ghelue. 2005. Polymorphisms in the genome of non-passaged human polyomavirus BK: implications for cell tropism and the pathological role of the virus. Virology 331:209-231.
37. Paracchini, V., S. Garte, P. Pedotti, F. Poli, S. Frison, and E. Taioli. 2005. Molecular identification of simian virus 40 infection in healthy Italian subjects by birth cohort. Mol. Med. 11:48-51.
38. Pipas, J. M. 1985. Mutations near the carboxyl terminus of the simian virus 40 large tumor antigen alter viral host range. J. Virol. 54:569-575.
39. Poulin, D. L., and J. A. DeCaprio. 2006. Is there a role for SV40 in human cancer? J. Clin. Oncol. 24:4356-4365.
40. Poulin, D. L., and J. A. DeCaprio. 2006. The carboxyl-terminal domain of large T antigen rescues SV40 host range activity in trans independent of acetylation. Virology 349:212-221.
41. Rochford, R., B. A. Campbell, and L. P. Villarreal. 1990. Genetic analysis of the enhancer requirements for polyomavirus DNA replication in mice. J. Virol. 64:476-485.
42. Rochford, R., J. P. Moreno, M. L. Peake, and L. P. Villarreal. 1992. Enhancer dependence of polyomavirus persistence in mouse kidneys. J. Virol. 66:3287-3297.
43. Rochford, R., and L. P. Villarreal. 1991. Polyomavirus DNA replication in the pancreas and in a transformed pancreas cell line has distinct enhancer requirements. J. Virol. 65:2108-2112.
44. Shah, K., and N. Nathanson. 1976. Human exposure to SV40: review and comment. Am. J. Epidemiol. 103:1-12.
45. Stewart, A. R., J. A. Lednicky, U. S. Benzick, M. J. Tevethia, and J. S. Butel. 1996. Identification of a variable region at the carboxy terminus of SV40 large T-antigen. Virology 221:355-361.
46. Stewart, A. R., J. A. Lednicky, and J. S. Butel. 1998. Sequence analyses of human tumor-associated SV40 DNAs and SV40 viral isolates from monkeys and humans. J. Neurovirol. 4:182-193.
47. Stratton, K., D. A. Alamario, and M. C. McCormick. 2003. Immunization safety review: SV40 contamination of polio vaccine and cancer. National Academies Press, Washington, DC.
48. Sugimoto, C., K. Hara, F. Taguchi, and Y. Yogo. 1989. Growth efficiency of naturally occurring BK virus variants in vivo and in vitro. J. Virol. 63:3195-3199.
49. 40. Proc. Soc. Exp. Biol. Med. 105:420-427.
50. Tevethia, M. J., J. M. Pipas, T. Kierstead, and C. Cole. 1988. Requirements for immortalization of primary mouse embryo fibroblasts probed with mutants bearing deletions in the 3′ end of SV40 gene A. Virology 162:76-89.
51. Vilchez, R. A., C. F. Brayton, C. Wong, P. Zanwar, D. E. Killen, J. L. Jorgensen, and J. S. Butel. 2004. Differential ability of two simian virus 40 strains to induce malignancies in weanling hamsters. Virology 330:168-177.
52. Vilchez, R. A., and J. S. Butel. 2004. Emergent human pathogen simian virus 40 and its role in cancer. Clin. Microbiol. Rev. 17:495-508.
53. Vilchez, R. A., C. A. Kozinetz, A. S. Arrington, C. R. Madden, and J. S. Butel. 2003. Simian virus 40 in human cancers. Am. J. Med. 114:675-684.
54. Vilchez, R. A., J. A. Lednicky, S. J. Halvorson, Z. S. White, C. A. Kozinetz, and J. S. Butel. 2002. Detection of polyomavirus simian virus 40 tumor antigen DNA in AIDS-related systemic non-Hodgkin lymphoma. J. Acquir. Immune Defic. Syndr. 29:109-116.
55. Weiner, L. P., R. M. Herndon, O. Narayan, R. T. Johnson, K. Shah, L. J. Rubinstein, T. J. Preziosi, and F. K. Conley. 1972. Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N. Engl. J. Med. 286:385-390.
56. Yogo, Y., and C. Sugimoto. 2001. The archetype concept and regulatory region rearrangement, p. 127-148. In K. Khalili and G. L. Stoner (ed.), Human polyomaviruses: molecular and clinical perspectives. Wiley-Liss, Inc., New York, NY.
57. zur Hausen, H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2:342-350.